Arcoma AB (ARCOMA) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Arcoma AB

Acarix AB

AroCell AB

Redsense Medical AB

SciBase Holding AB

Dignitana AB

Clinical Laserthermia Systems AB

Ziccum AB

Glycorex Transplantation AB

Episurf Medical AB

Irras AB

Why is Arcoma AB ?

Flat results in Mar 26

ROCE(HY) Lowest at 5.55%
PRE-TAX PROFIT(Q) At SEK 1.02 MM has Fallen at -35.17%
NET PROFIT(Q) At SEK 0.81 MM has Fallen at -35.52%

With ROE of 6.73%, it has a fair valuation with a 1.64 Price to Book Value

Over the past year, while the stock has generated a return of -11.27%, its profits have fallen by -49%

Below par performance in long term as well as near term

Along with generating -11.27% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Arcoma AB should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Arcoma AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Arcoma AB

-11.27%

-0.90

49.47%

OMX Stockholm 30

30.13%

1.89

15.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

2.18%

EBIT Growth (5y)

18.40%

EBIT to Interest (avg)

3.04

Debt to EBITDA (avg)

Net Debt is too low

Net Debt to Equity (avg)

-0.13

Sales to Capital Employed (avg)

2.47

Tax Ratio

26.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

11.35%

ROE (avg)

6.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.64

EV to EBIT

10.07

EV to EBITDA

5.46

EV to Capital Employed

2.22

EV to Sales

0.67

PEG Ratio

Dividend Yield

ROCE (Latest)

22.04%

ROE (Latest)

6.73%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 21.36 MM

CASH AND EQV(HY)

Highest at SEK 69.26 MM

DEBT-EQUITY RATIO (HY)

Lowest at -44.93 %

-8What is not working for the Company

ROCE(HY)

Lowest at 5.55%

PRE-TAX PROFIT(Q)

At SEK 1.02 MM has Fallen at -35.17%

NET PROFIT(Q)

At SEK 0.81 MM has Fallen at -35.52%

RAW MATERIAL COST(Y)

Grown by 86.84% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.31 times

Here's what is working for Arcoma AB

Operating Cash Flow

Highest at SEK 21.36 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Cash and Eqv

Highest at SEK 69.26 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Debt-Equity Ratio

Lowest at -44.93 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Arcoma AB

Pre-Tax Profit

At SEK 1.02 MM has Fallen at -35.17%

over average net sales of the previous four periods of SEK 1.58 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (SEK MM)

Net Profit

At SEK 0.81 MM has Fallen at -35.52%

over average net sales of the previous four periods of SEK 1.26 MM

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (SEK MM)

Inventory Turnover Ratio

Lowest at 4.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 86.84% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales